Oncotelic Therapeutics
OTLC · OTC
$0.0176−$0.0009 (−4.86%)TodayMarket closed ·
Prev close $0.0185
Who owns OTLC
Largest institutional holders, from their latest 13F filings
The 7 largest institutions hold 44.9% of OTLC’s shares.
- Trieu (Vuong)25.4%
- Bhakta (Balaji)9.4%
- Hwang (Larn Ph.D.)5.3%
- Saund (Sarana)3.7%
- Next 3 largest institutions1.1%
- All other shareholders55.1%
| Holder | Shares | % of shares |
|---|---|---|
| Trieu (Vuong) | 112.74M | 25.41% |
| Bhakta (Balaji) | 41.63M | 9.38% |
| Hwang (Larn Ph.D.) | 23.46M | 5.29% |
| Saund (Sarana) | 16.46M | 3.71% |
| King (Steven W) | 3.33M | 0.75% |
| Maida (Anthony E III) | 1.14M | 0.26% |
| Shah (Amit B) | 378.84K | 0.09% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $37.83K (7 trades) of OTLC on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Fein Seymour Howard | Award | 250 | — |
| KING STEVEN W | Award | 250 | — |
| Saund Saran | Award | 1.50K | — |
| Shah Amit B. | Award | 1.50K | — |
| Trieu Vuong | Award | 2.00K | — |
| MAIDA ANTHONY E III | Award | 1.50K | — |
| Trieu Vuong | Buy | 240.00K | $10.34K |
| Trieu Vuong | Buy | 115.00K | $5.18K |
| Trieu Vuong | Buy | 75.00K | $3.38K |
| Trieu Vuong | Buy | 65.00K | $2.93K |
Short interest
Settled Sep 30, 2026
- Shares short
- 15.87K
- Days to cover
- 1.00
- % of shares outstanding
- 0.00%
- Average daily volume
- 869.56K
- Change since last report
- +20.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.